Missed two weeks of Wegovy injections: what actually happens

The myth that a two-week gap is fine to just pick up from

A common assumption is that semaglutide stays in your system so long that a couple of missed weeks barely matter. There's something to the pharmacology (semaglutide has a half-life of around seven days, so it does linger longer than most medicines) but this doesn't mean you can simply continue at the same dose after two weeks away. The guidance in the Wegovy SmPC on the eMC is specific: if more than five days have passed since your scheduled injection, skip that dose and take your next one on the usual day. Two weeks places you well past that window, and clinical practice typically treats a gap this long as a reason to reassess your dose level before continuing.

The reason matters. When you first start Wegovy, gastro-intestinal side effects are most noticeable precisely because your body is adjusting to semaglutide's effects on gastric emptying and appetite signalling. Titrating slowly from 0.25mg upwards is designed to let that adjustment happen gradually. After two weeks without the medicine, some of that tolerance can wane. Jumping back to a higher dose raises your odds of significant nausea or vomiting, the side effects people find hardest to manage. Picking up exactly where you left off is the myth; the fact is that a restart discussion with your prescriber is usually the right first step. See our page on what to do after a missed Wegovy dose for the single-week guidance too.

What a two-week gap actually does to your progress

Two weeks off Wegovy is unlikely to undo significant weight-loss progress, but appetite can return noticeably as blood levels of semaglutide fall. Some people describe hunger coming back with force, which can feel discouraging. That's a physiological response, not a failure, semaglutide suppresses appetite partly through its action on GLP-1 receptors in the brain, and as levels drop, that suppression eases. The NHS semaglutide medicines page describes the medicine's mechanism clearly if you want the detail: NHS guidance on semaglutide.

Practically, the gap also disrupts the weekly routine that makes injection therapy sustainable. For many people, the injection becomes as habitual as checking the pen in the fridge door on a Sunday morning; two weeks off that rhythm can make restarting feel harder than it actually is. The clinical answer is straightforward, contact your prescriber, explain the gap, and let them confirm whether you restart at your current dose or step back a level. It is a short conversation, and it is far better than guessing. For context on the full Wegovy dose schedule, our guide to Wegovy doses sets out the titration pathway from 0.25mg upward.

There is no published trial data specifically studying the effects of a two-week treatment break, so anyone citing precise figures about weight regain in a fortnight is speculating. What is established from the STEP programme is that sustained use of semaglutide 2.4mg produces meaningful weight reduction over 68 weeks, the STEP 1 trial, published in the New England Journal of Medicine, reported an average of around 15% body-weight reduction at that dose. Consistency matters.

Restarting safely: the clinician's role and what nume cannot decide for you

This is the practical section. After a two-week gap, you should contact whoever prescribes your Wegovy before your next injection. Your prescriber will consider your current dose, how long you were on it before the break, and whether you experienced any side effects at that level. In many cases, stepping back one dose rung for four weeks is the cautious approach; in others, continuing at the same dose is appropriate. That decision belongs to the clinician. What you should not do is look up a protocol online and apply it yourself, the variables genuinely differ between patients.

If you are also thinking about the cost of Wegovy treatment during a break, it is worth knowing that a two-week pause does not alter how the treatment is prescribed for the next supply; clinical re-review happens at every repeat order regardless of whether there was a gap. For longer absences, some people find it useful to read about what happens after missing Wegovy for three weeks, where the restart guidance becomes firmer still. And if your gap was closer to seven or eight days rather than a full two weeks, the one-week missed dose page covers that scenario directly.

Wegovy (semaglutide) is a prescription-only medicine, and the prescriber who reviews your treatment bears clinical responsibility for your safety, that is exactly why the system is designed this way. If you are not currently being treated and are looking at whether Wegovy is right for you, the broader Wegovy overview explains eligibility, how the titration works, and how a private prescription route differs from the NHS pathway.

When a gap becomes a reason to reconsider the whole plan

Sometimes two missed weeks are not accidental, they reflect difficult side effects, a holiday where storage was impractical, or simply losing confidence in the treatment. All of these are worth discussing openly with your prescriber. Side effects that made you want to stop are clinically relevant information: they might point to a slower titration, anti-nausea support strategies, or a review of whether Wegovy remains the right choice. The usual Wegovy dose page covers how the maintenance dose is reached and why some people take longer to get there.

If you are considering your options more broadly (including how Wegovy compares with other licensed treatments) the weight-loss treatment overview gives an honest summary. A clinical conversation is free at nume, and it is there specifically for questions like this one: not a sales call, just a prescriber who can look at the full picture and tell you plainly where to go next. Check your eligibility and start that conversation at our treatment page.